Back to results
US 5,849,922 AGranted
Preparation of substituted alkenoic acids
AssigneeEli Lilly and Company
InventorsKatrina Ann Nelson, Joseph John Nunes
Life of this patent
Estimating the term…
Abstract
This invention relates to a highly selective process for preparation of E-.omega.-phenyl-.omega.-(3-pyridyl)-.omega.-alkenoic acid derivatives bearing a carbamoyl substituted oxazolyl or oxazolinyl group on the phenyl ring which demonstrate utility for thromboxane receptor antagonism and/or thromboxane synthase inhibition, as well as to intermediates therefor.
Claims22
A process for the preparation of a compound of Formula E-I ##STR40## wherein n is 2, 3, 4 or 5;
- L is ortho-, meta- or para-phenylene;
- each R.sup.a is hydrogen or the two together form a double bond;
- and
- R is (3-12C)alkyl, (3-12C)alkenyl, (3-12C)alkynyl, 2-phenylcyclopropyl or R.sup.b -(1-6C)alkyl in which R.sup.b is (3-8C)cycloalkyl, phenyl, tetrahydropyranyl, morpholino, piperidino or pyrrolidino wherein a phenyl group of the radical R may bear a 4-substituent selected from halo, (1-2C)alkyl and (1-2C)alkoxy;
- a cyclohexyl group of the radical R may bear a 4-substituent selected from (1-2C)alkyl and (1-2C)alkoxy;
- and in which one or two methylene groups of a (3-12C)alkyl, (3-12C)alkenyl, (3-12C)alkynyl, or the alkyl portion of R.sup.b -(1-6C)alkyl may be replaced by an oxy group;
- and further provided that at least two carbon atoms separate any oxygens or nitrogens in the residue --NHR;
- or a pharmaceutically acceptable salt thereof, which comprises
- (i) cross coupling a compound of Formula VIII ##STR41## with a compound of Formula IX ##STR42## in the presence of a catalyst Q wherein the cross coupling reaction is the Stille reaction;
- one of Y and Z is bromo, iodo, or trifluoromethylsulfonyloxy (TfO);
- the other of Y and Z is SnR.sup.t 3, wherein R.sup.t is lower alkyl;
- and Q is a Stille catalyst;
- and
- --COOR.sup.p represents a carboxy group in a protected form stable to the cross coupling conditions
- to afford a compound of Formula E-II, ##STR43## and (ii) converting the protected carboxy group --COOR.sup.p into the carboxy group --COOH;
- and
- whereafter, when a pharmaceutically acceptable salt of a compound of Formula E-I is required, it is obtained by reacting the acid of Formula E-I with a physiologically acceptable base or by reacting a basic compound of Formula E-I with a physiologically acceptable acid or by any other conventional procedure.
14 more elements
Dependencies are inferred from the claim text.